[phil]

While its true that Gen. wanted the drug approved , it was w/ mixed motives. $$ is always afactor in their top CEOS decision-making. Some in the co. wanted to close Expanded Access right after the FDA declined approval. But were persuaded not to. Also did not extend access to much of the country , after FDA denial. No return on their investment. Now they have closed access. And they are keeping my wife from Boston, w/ low platelets shes an investment risk.
So FDA is the main problem here, but we need an FDA that works for us, and keeps an eye on how Big Business sells medicines. While they make wonderful dugs, and want to save lives, they also will make BILLIONS per year on this drug . Dont be fooled. The top execs at Gen. are as far removed from the chemo rooms as Dr. Pazdur over at the FDA. The Systemis crooked. Witness how this FDA handles so-called compassionate use, they tell pts, " Dont contact us, have your doc call the Co. IF THE CO. SAYS OK , we'll review it. Many co's wont give single pt or so -called comp. use, becuas eits an INVESTMENT RISK ! What if you have an un-related health crisis on thier drug. If youre Gen. , w/ this antagonistic FDA, you are screwed, so Speak up ! This FDA Oncology Review Div. needs an overhaul, and some real compassion for Stage IV pts.